AI-Powered Precision in Antibody Drug Development

At Creative Biolabs, we leverage our proprietary AI-enhanced technology to offer comprehensive, end-to-end antibody services. From de novo generation and screening to design, optimization, and engineering, we accelerate your drug development timelines and significantly reduce your time-to-market. We're here to streamline your journey and unlock the full potential of your therapeutic antibodies.

Explore what we can do

What we can do

AI-Driven Antibody Discovery

Leveraging advanced generative AI models and high-throughput computational screening, we accelerate the identification and de novo design of novel therapeutic antibody sequences with optimized binding characteristics. This platform utilizes protein motion simulation and deep learning to explore vast sequence space, significantly reducing traditional development timelines.

AI-Driven Antibody Screening

Our AI intelligently optimizes high-throughput screening strategies, enabling the efficient analysis of massive datasets. This allows us to rapidly and accurately pinpoint the best antibodies from vast candidate libraries, dramatically boosting your R&D efficiency.

AI-Driven Antibody
Design

Our AI precisely predicts antibody sequences and 3D structures, allowing us to accurately optimize affinity, stability, and developability. We also provide specialized designs for complex applications like multi-specific antibodies and ADCs, helping to accelerate the success of your innovative antibody drugs.

AI-Driven Antibody Engineering

Employing sophisticated machine learning algorithms and computational biology, we optimize lead candidates across critical biophysical attributes, including affinity maturation, humanization, and stability. Our predictive models forecast developability, ensuring enhanced efficacy and minimal immunogenicity for clinical success.

AI-Driven Small Molecule
Drug Discovery

We're accelerating traditional small molecule drug development by empowering target identification, high-throughput screening, and molecular design with AI. Our intelligent algorithms broaden your drug discovery path, helping you find novel compounds faster.

Empowering target identification

High-throughput screening

Molecular design

Small Molecule Drug Discovery

Model Training Data Services

Based on our AI-aided drug discovery solutions, Creative Biolabs provides the best strategy and customized protocols for model training data service, and ultimately, to accelerate the novel candidate drug discovery.

AI-based One-stop
Antibody Discovery Platform

Creative Biolabs offers customized solutions from de novo antibody creation and AI-augmented screening to AI-driven design and engineering final to phage display. Aided by this platform, we provide one-stop human antibody discovery services, including antibody-antigen binding prediction, antibody candidate generation, antibody sequence optimization, antibody production & characterization, etc.